Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 2 |
Descriptor
| Neuropsychology | 2 |
| Pain | 2 |
| Patients | 2 |
| Sleep | 2 |
| Attention Deficit Disorders | 1 |
| Attention Deficit… | 1 |
| Brain Hemisphere Functions | 1 |
| Check Lists | 1 |
| Cognitive Processes | 1 |
| Comparative Analysis | 1 |
| Control Groups | 1 |
| More ▼ | |
Source
| Brain | 1 |
| Child Psychiatry and Human… | 1 |
Author
| Agaoglu, Belma | 1 |
| Bogdahn, U. | 1 |
| Karakaya, Isik | 1 |
| Luerding, R. | 1 |
| Memik, Nursu Cakin | 1 |
| Schmidt-Wilcke, T. | 1 |
| Sismanlar, Sahika G. | 1 |
| Weigand, T. | 1 |
| Yildiz, Ozlem | 1 |
Publication Type
| Journal Articles | 2 |
| Reports - Evaluative | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkYildiz, Ozlem; Sismanlar, Sahika G.; Memik, Nursu Cakin; Karakaya, Isik; Agaoglu, Belma – Child Psychiatry and Human Development, 2011
The aim of this study was to compare the safety, efficacy, tolerability, and the effects of atomoxetine and OROS-MPH on executive functions in children with ADHD. This study was an open-label study that only included two medication groups. Children were randomized to open-label atomoxetine or OROS-MPH for 12 weeks. Primary efficacy measures were…
Descriptors: Pain, Safety, Attention Deficit Hyperactivity Disorder, Patients
Luerding, R.; Weigand, T.; Bogdahn, U.; Schmidt-Wilcke, T. – Brain, 2008
Fibromyalgia (FM) is a disorder of unknown aetiology, characterized by chronic widespread pain, stiffness and sleep disturbances. In addition, patients frequently complain of memory and attention deficits. Accumulating evidence suggests that FM is associated with CNS dysfunction and with an altered brain morphology. However, few studies have…
Descriptors: Control Groups, Test Results, Pain, Sleep
